AstraZeneca to Sell Caprelsa to Sanofi's Genzyme for Up to $300M
July 27, 2015 at 05:29 AM EDT
AstraZeneca (NYSE: AZN) today announced that it has entered into a definitive agreement with Genzyme (NYSE: SNY) to divest Caprelsa® ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.